STOP-Coronavirus: Clinical, Immunological, Genomic, Virological and Bioethical Factors of COVID-19

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:2 publications

Grant number: COV20_00181

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principal Investigator

    José María Aguado García
  • Research Location

    Spain
  • Lead Research Institution

    FUNDACION INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen genomics, mutations and adaptations

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Individuals with multimorbidityOtherUnspecified

  • Occupations of Interest

    Unspecified

Abstract

WPs]) over 12 months: WP0 (cross-sectional): constitution of a prospective cohort of patients with COVID-19, clinical characterization and collection of biological samples (HU12O, HUFJD / IIS-FJD, HCUVA, HUIE); WP1 (clinical): predictive model based on clinical and biochemical variables (HU12O); WP2 (immune): immune response to SARS-CoV-2 (HU12O, HCUVA); WP3 (genomic): host genetic prognostic markers (HUFJD / IIS-FJD, HCUVA); WP4 (immunosuppressed): COVID-19 in oncohematological and transplant patients (HU12O, HUFJD, HCUVA); WP5 (therapeutic): response to antiviral and immunomodulatory treatment (HU12O); WP6 (bioethical): socio-economic analysis and ethical repercussions (HUIE, HUFJD, HCUVA); and WP7 (virological): viral dynamics and spectrum of SARS-CoV-2 mutants.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Novel risk loci for COVID-19 hospitalization among admixed American populations.

Novel genes and sex differences in COVID-19 severity.